{content}

Study list

Post-Covid UKF

Germany
|
2021
  • Adults
  • General population
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

LUNGTERMcov

Switzerland
|
2021-2023
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

Steinmetz

Germany
|
2021
  • General population
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

COVIMMUNE-Clin

Germany
|
2021
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19

D’Hondt

Belgium
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

EXER-COVID

Spain
|
2021-2022
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Perrotta

Italy
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Fragile population
  • Hospital wide
  • Emergency department
  • Infectious diseases unit
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab
  • Bamlanivimab/ Etesevimab

Christensen

Denmark
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

DYSCO

Belgium
|
2021
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

SILENT 2

Belgium
|
2021-2023
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

LoTECA

Norway
|
2021-2022
  • Adults
  • General population
  • Paediatric
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Blood sample
  • Stool sample

Liira

Finland
|
2021-2023
  • Adults
  • General population
  • Outpatient clinic
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19